Sunway Healthcare Records RM95.17 Million Profit in Third Quarter
PETALING JAYA: Sunway Healthcare Holdings Bhd (Sunmed) recorded a 59.5 per cent increase in net profit to RM95.17 million for the third quarter ended September 30, 2026, compared with RM59.69 million in the same period last year.
The strong performance was driven by operational revenue growth following increased demand for healthcare services nationwide, alongside higher operating income and lower net finance costs.
Revenue for the quarter rose 24 per cent to RM737.44 million from RM593.13 million previously, supported by sustained patient demand, higher hospital utilisation and increased contributions from Sunway Medical Centres (SMC) in Ipoh, Damansara, Velocity and Penang.
Its president, Datuk Lau Beng Long, said Sunway Healthcare would continue to license and operationalise its remaining capacity in phases, particularly at Tower F of SMC Bandar Sunway, SMC Damansara and SMC Ipoh.
“At the same time, brownfield development programmes at SMC Damansara and SMC Penang, as well as ongoing greenfield initiatives and Ambulatory Care Centres, are expected to provide additional capacity to support the group’s medium- and long-term growth,” he said in a filing to Bursa Malaysia.
The bed occupancy rate improved to 77 per cent from approximately 71 per cent in the third quarter of 2025, reflecting stronger utilisation of the group’s operating capacity.
Inpatient admissions increased 21 per cent year-on-year to 36,541 patients, while average revenue per inpatient admission rose five per cent to RM12,339 during the quarter.
For the first nine months of the 2026 financial year, Sunway Healthcare’s net profit increased 48 per cent to RM206.66 million from RM139.83 million in the corresponding period last year, while revenue rose 26 per cent to RM2.00 billion from RM1.59 billion.
As of September 30, the group had 1,994 licensed beds and 277 completed beds ready for licensing, bringing its total capacity to 2,271 beds.
Commenting on MediAsas and the phased implementation of the diagnosis-related group (DRG) framework, Beng Long said the group would continue to engage constructively with insurance companies, takaful operators and relevant stakeholders.
“The group expects margins to be protected through disciplined pricing and discount governance, procurement initiatives, clinical cost management and continuous improvements in operational productivity,” he said.
He added that medical tourism remained an important growth opportunity, supported by Malaysia’s position as a regional healthcare destination.
“The group will continue to expand its international patient source markets, strengthen referral and insurance partnerships, and enhance higher-value specialist offerings while remaining vigilant about geopolitical developments and regional travel uncertainties.
“With an established hospital network, expanding specialist capabilities and increasing capacity, the group remains focused on translating patient volume growth and phased capacity activation into sustainable earnings while maintaining clinical excellence, operational resilience and financial discipline,” he said.
No dividend was declared for the quarter.
UTUSAN